Collective intelligence can help reduce medical misdiagnoses
A fully automated solution significantly increases diagnostic accuracy
Researchers from the Max Planck Institute for Human Development, the Institute for Cognitive Sciences and Technologies (ISTC), and the Norwegian University of Science and Technology developed a collective intelligence approach to increase the accuracy of medical diagnoses. Their work was recently presented in the journal PNAS.
An estimated 250,000 people die from preventable medical errors in the U.S. each year. Many of these errors originate during the diagnostic process. A powerful way to increase diagnostic accuracy is to combine the diagnoses of multiple diagnosticians into a collective solution. However, there has been a dearth of methods for aggregating independent diagnoses in general medical diagnostics. Researchers from the Max Planck Institute for Human Development, the Institute for Cognitive Sciences and Technologies (ISTC), and the Norwegian University of Science and Technology have therefore introduced a fully automated solution using knowledge engineering methods.
The researchers tested their solution on 1,333 medical cases provided by The Human Diagnosis Project (Human Dx), each of which was independently diagnosed by 10 diagnosticians. The collective solution substantially increased diagnostic accuracy: Single diagnosticians achieved 46% accuracy, whereas pooling the decisions of 10 diagnosticians increased accuracy to 76%. Improvements occurred across medical specialties, chief complaints, and diagnosticians’ tenure levels. “Our results show the life-saving potential of tapping into the collective intelligence,” says first author Ralf Kurvers. He is a senior research scientist at the Center for Adaptive Rationality of the Max Planck Institute for Human Development and his research focuses on social and collective decision making in humans and animals.
Collective intelligence has been proven to boost decision accuracy across many domains, such as geopolitical forecasting, investment, and diagnostics in radiology and dermatology (e.g., Kurvers et al., PNAS, 2016). However, collective intelligence has been mostly applied to relatively simple decision tasks. Applications in more open-ended tasks, such as emergency management or general medical diagnostics, are largely lacking due to the challenge of integrating unstandardized inputs from different people. To overcome this hurdle, the researchers used semantic knowledge graphs, natural language processing, and the SNOMED CT medical ontology, a comprehensive multilingual clinical terminology, for standardization.
“A key contribution of our work is that, while the human-provided diagnoses maintain their primacy, our aggregation and evaluation procedures are fully automated, avoiding possible biases in the generation of the final diagnosis and allowing the process to be more time- and cost-efficient,” adds co-author Vito Trianni from the Institute for Cognitive Sciences and Technologies (ISTC) in Rome.
The researchers are currently collaborating – along with other partners – within the HACID project to bring their application one step closer to the market. The EU-funded project will explore a new approach that brings together human experts and AI-supported knowledge representation and reasoning in order to create new tools for decision making in various domains. The application of the HACID technology to medical diagnostics showcases one of the many opportunities to benefit from a digitally based health system and accessible data.
Original publication
Ralf H. J. M. Kurvers, Andrea Giovanni Nuzzolese, Alessandro Russo, Gioele Barabucci, Stefan M. Herzog, Vito Trianni; "Automating hybrid collective intelligence in open-ended medical diagnostics"; Proceedings of the National Academy of Sciences, Volume 120, 2023-8-14
Ralf H. J. M. Kurvers, Stefan M. Herzog, Ralph Hertwig, Jens Krause, Patricia A. Carney, Andy Bogart, Giuseppe Argenziano, Iris Zalaudek, Max Wolf; "Boosting medical diagnostics by pooling independent judgments"; Proceedings of the National Academy of Sciences, Volume 113, 2016-7-18
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
